Analyst consensus rating
Omada Health Analyst Rating: Buy
OMDA is rated Buy by 12 analysts with a $28.25 target. As of 2026-08-19.
Direct answer
Omada Health's consensus rating is Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $28.25.
Forecast evidence checked August 19, 2026.
Get free Omada Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $24.23
- Average price target
- $28.25
- High price target
- $35.00
- Low price target
- $22.00
- Low target gap
- -9.2%
- Target upside
- +16.6%
- High target gap
- +44.4%
- Target range width
- 53.7%
- Consensus rating
- Buy
- Analysts
- 12
- Evidence date
- August 19, 2026
- Valid through
- August 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Omada Health?
Omada Health has a verified Buy consensus. The same dataset has an average price target of $28.25.
How far are Omada Health's low and high targets from the recorded price?
The low target implies -9.2%, while the high target implies +44.4%.
How many analysts are included in Omada Health's consensus?
The verified consensus includes 12 analysts.
How is Omada Health's target upside or downside calculated?
The average target of $28.25 is divided by the recorded price of $24.23, then one is subtracted to produce +16.6%. This does not guarantee a future return.
When was Omada Health's analyst forecast verified?
The data was verified on 2026-08-19. The dataset is valid through 2026-08-26.